|1||NCT03152058||Recruiting||IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy||
||50||Female||18 Years to 38 Years (Adult)||NCT03152058||94818||May 17, 2017||May 2020||May 2021||May 12, 2017||March 13, 2019||
|2||NCT02295475||Active, not recruiting||Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome||
||Other / Industry||
||200||All||18 Years and older (Adult, Older Adult)||NCT02295475||CV185-357
|ASTRO-APS||December 10, 2014||April 2021||July 2021||November 20, 2014||June 17, 2019||
† Study has passed its completion date and status has not been verified in more than two years.